Related Experiment Video
Updated: Jan 3, 2026

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
7.1K
When basal cell carcinomas became giant: an Italian multicenter study
Giulio Gualdi1, Paola Monari2, Piergiacomo Calzavara-Pinton2
1Department of Medicine and Aging Science and Dermatologic Clinic, University "G. d'Annunzio", Chieti-Pescara, Chieti, Italy.
International Journal of Dermatology
|November 28, 2019
Summary
Giant basal cell carcinoma (GBCC) is rare, often developing due to delayed treatment or ineffective prior therapies. Understanding its characteristics aids in choosing better treatment strategies for basal cell carcinoma (BCC).
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Giant basal cell carcinoma (GBCC) is defined as a basal cell carcinoma (BCC) exceeding 5 cm in diameter.
- GBCCs are rare, accounting for only 0.5-1% of all BCCs, with limited data on their development.
- Causes and specific characteristics of GBCC development remain poorly understood.
Purpose of the Study:
- To investigate the causative factors of GBCC.
- To analyze the clinico-histological features of GBCC.
Main Methods:
- A 6-month, hospital-based case series study.
- Involved 12 Italian dermatologic centers.
- Collected data from 59 GBCC cases and 458 control BCCs.
Main Results:
- No significant social or cultural differences were found between GBCC and control groups.
- GBCCs had a longer duration, were located on unexposed areas, and were more frequently of the infiltrative histological subtype compared to BCCs.
- GBCCs demonstrated significantly higher local invasiveness, greater metastatic potential, and over half had prior treatments.
Conclusions:
- GBCC patients typically fall into two groups: those with delayed medical attention or those with previously inadequately treated BCCs.
- Intrinsic tumor aggressiveness is rarely the sole cause of GBCC.
- Social and cultural factors do not appear to influence GBCC development, guiding clinicians toward appropriate therapeutic strategies for BCCs that may progress to GBCC.
Related Concept Videos
Skin Cancer
5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K

